Best Telehealth Clinics in Arkansas (2026)

Arkansas has one of the strictest telehealth controlled substance prescribing frameworks in the country. Under Ark. Code §§ 17-80-402, 17-80-403, and 17-80-404 (the Arkansas Telemedicine Act), a physician using telemedicine may not prescribe Schedule II through V controlled substances unless the physician has seen the patient in person. Exceptions exist only for consultation/referral relationships, on-call/cross-coverage situations, and ongoing professional relationships.

This in-person requirement is stricter than the federal DEA telemedicine flexibility extension, which allows telehealth-only prescribing through December 2026. Arkansas law overrides the federal flexibility — providers cannot prescribe testosterone or other controlled substances to Arkansas patients without a prior in-person evaluation, regardless of the DEA waiver.

Online questionnaires alone do not establish a valid physician-patient relationship in Arkansas. Telehealth may only be used to prescribe non-controlled drugs after establishing a relationship through an appropriate encounter.

Arkansas passed IMLC legislation but implementation has not been fully completed as of March 2026. The state is effectively not yet an active IMLC member, which further limits telehealth provider access. Providers must obtain a standard Arkansas medical license, which is a slower process than IMLC-expedited licensure.

Arkansas has reduced NP practice authority. APRNs must operate under a collaborative agreement with a physician and require 300 hours of experience before autonomous prescribing. This limits NP-staffed telehealth platforms.

Arkansas Medicaid does not cover GLP-1 receptor agonists for obesity. HB 1332 to evaluate GLP-1 coverage did not advance through the legislature. Coverage is limited to diabetes indications.

The combination of mandatory in-person visits for controlled substances, pending IMLC status, and reduced NP practice authority makes Arkansas one of the most difficult states for telehealth platforms to serve. Both TRT Nation and Enhance MD explicitly exclude Arkansas.

Arkansas has 3.0 million residents. Provider availability for controlled substance telehealth is among the lowest in the country due to the mandatory in-person requirement under §§ 17-80-402 through 17-80-404.

TRT Nation explicitly excludes Arkansas. Enhance MD also excludes the state. All-50-state providers like Maximus ($100/mo) and Hone Health ($25/mo) technically list Arkansas, but the in-person requirement means these platforms must coordinate local evaluations before telehealth prescribing. Verify actual operational availability before enrolling.

GLP-1 availability is better since GLP-1s are not controlled substances. The in-person requirement does not apply. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, and Mochi Health serve Arkansas. No Medicaid GLP-1 obesity coverage.

HRT, hair loss, and ED providers with national coverage generally serve Arkansas for non-controlled medications. Controlled substance prescriptions face the same in-person barrier as TRT.

TRT pricing from providers that may serve Arkansas: DudeMeds $77/mo ($1,124/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year). TRT Nation ($99/mo) does not serve Arkansas. The mandatory in-person visit adds $150 to $400 in indirect costs.

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Arkansas Medicaid does not cover GLP-1s for obesity. Patients pay the full out-of-pocket cost.

Arkansas does not tax prescription medications. The state sales tax is 6.5% (plus local taxes) but Rx drugs are exempt. Arkansas has a flat income tax of 3.9% on income over $4,600.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.

TRT (testosterone replacement therapy)

Arkansas requires an in-person visit before prescribing controlled substances via telehealth (§§ 17-80-402 through 17-80-404). This state requirement is stricter than the federal DEA waiver. TRT Nation and Enhance MD exclude Arkansas. Providers claiming "all 50 states" face significant compliance risk. Reduced NP practice authority further limits options.

GLP-1 weight loss

No state-specific GLP-1 restrictions. The in-person requirement does not apply to non-controlled substances. Federal FDA compounding rules apply. Arkansas Medicaid does not cover GLP-1s for obesity.

HRT (hormone replacement therapy)

Non-controlled HRT medications are not subject to the in-person requirement. Standard federal prescribing rules apply.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Arkansas. No additional state restrictions apply for non-controlled medications.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Arkansas. No additional state restrictions apply for non-controlled medications.

Peptides

Controlled peptides are subject to the in-person requirement. Non-controlled peptides like BPC-157 and sermorelin follow standard federal rules.